Log-in
E-Mail
Passwort
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Neukunde
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

4-Traders Homepage  >  Aktien  >  Toronto Stock Exchange  >  VANC Pharmaceuticals Inc    APH   CA92143R2046

Schlusskurs. Schlusskurs  - 22.01
0.4 CAD   0.00%
2016 VANC PHARMACEUT : REVERSE SPLIT: 1 for 4
2012 ALDA PHARMACEUT : REVERSE SPLIT: 1 for 10
 ÜbersichtChartsNewsUnternehmen 
Kurse 1 Woche   Schlusskurs. Schlusskurs Toronto Stock Exchange
16.01.2018 17.01.2018 18.01.2018 19.01.2018 22.01.2018 Datum
0.435 0.44 0.43 0.4 0.4 Kurs
216031 174225 85206 330563 567682 Volumen
-3.33% +1.15% -2.27% -6.98% 0.00% Veränderung
Unternehmensprofil
Vanc Pharmaceuticals, Inc. engages in the manufacture and sale of over-the-counter healthcare products.Its products include Hema-fer (Natural iron supplement for iron deficiency and anemia), Cortivera (Hydrocortisone cream/ointment in combination with Aloe Vera), and Sennace (Sennoside... 
Branche
Pharmaceuticals
Termine
-
Weitere Informationen über das Unternehmen
Aktuelle News zu VANC PHARMACEUTICALS INC
2016 VANC PHARMACEUTICALS INC : REVERSE SPLIT: 1 for 4
2012 ALDA PHARMACEUTICALS : REVERSE SPLIT: 1 for 10
Mehr News
News auf Englisch zu VANC PHARMACEUTICALS INC
11:34 VANC PHARMACEUTICALS : Branding An Emerging Focus as Adult-Use Legalization Spre..
19.01. VANC PHARMACEUTICALS : Nuuvera and Aphria finalize offtake agreement for extra 6..
18.01. CANNABIS WHEATON INCOME : Announces International Supply Agreement With Aphria
17.01. VANC PHARMACEUTICALS : Cannabis Wheaton Announces International Supply Agreement..
15.01. VANC PHARMACEUTICALS : Health-care sector boosts Toronto stocks, loonie tops 80 ..
15.01. VANC PHARMACEUTICALS : Aphria buying Broken Coast Cannabis for $230 million in s..
15.01. VANC PHARMACEUTICALS : Ladysmith marijuana producer bought by Aphria in $230M de..
15.01. VANC PHARMACEUTICALS : Aphria strengthens portfolio with acquisition of leading ..
15.01. VANC PHARMACEUTICALS : Aphria Continues Expansion into Australia with Strategic ..
10.01. AURORA CANNABIS : Most actively traded companies on the TSX
Mehr News auf Englisch
Branchenachrichten : Biopharmaceuticals
18:15 Gipfelstürmerei im DAX geht weiter – Bayer nutzt die Gelegenheit
17:00 Investmentbankerin wechselt zu Wohnungskonzern Vonovia
14:32 WDH : Johnson & Johnson trifft 2017 eigene Prognose - Steuerreform drückt Gewinn
14:04 Johnson & Johnson trifft 2017 eigene Prognose - Steuereform drückt Gewinn
13:30 AUSBLICK NOVARTIS : Jahresumsatz von 48,6 Mrd bis 50,1 Mrd USD erwartet
Mehr Branchennews : Biopharmaceuticals
Neuesten Tweets
2017VANC Pharmaceuticals Executes Share Purchase Agreement to Acquire HealthTab I.. 
2017Emerald Health takes 6.5% stake in Vanc Pharmaceuticals; shares down 6%  
2017BRIEF-Emerald Health Therapeutics Acquires Shares Of Vanc Pharmaceuticals  
2017Emerald Health Therapeutics, Inc. Acquires Shares of Vanc Pharmaceuticals Inc.. 
2017VANC Pharmaceuticals Closes Oversubscribed Private Placement  
Mehr tweets
Qtime:12
Chart VANC PHARMACEUTICALS INC
Laufzeit : Zeitraum :
VANC Pharmaceuticals Inc : Chartanalyse VANC Pharmaceuticals Inc | APH | CA92143R2046 | 4-Traders
Trends aus der Chartanalyse VANC PHARMACEUTICALS INC
KurzfristigMittelfristigLangfristig
TrendsNeutralAnsteigendAnsteigend
Vorstände
NameTitel
Sukhwinder Singh Rai Chief Executive Director & Executive Director
David M. Hall Chairman
Eugene Beukman Chief Financial Officer & Secretary
Alan Arnstein Independent Director
Sherif Guorgui Director
Branche und Wettbewerber
01.01.Marktkap. (M$)
VANC PHARMACEUTICALS INC17.65%0
BIOGEN7.48%73 518
CSL LIMITED2.90%52 543
ALEXION PHARMACEUTICALS1.22%27 629
GRIFOLS SA7.27%20 136
BIOMARIN PHARMACEUTICAL-0.06%16 106